Baker Biotech Capital (GP), LLC Insider Trading $NRGN NEUROGEN CORP
Get free email notifications about insider trading for Baker Biotech Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Biotech Capital (GP), LLC. Baker Biotech Capital (GP), LLC is 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in NEUROGEN CORP ($NRGN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and 10% Owner in PHARMACYCLICS INC ($PCYC) and 10% Owner in VIROPHARMA INC ($VPHM) and 10% Owner in ADOLOR CORP ($ADLR) and 10% Owner in ALLOS THERAPEUTICS INC ($ALTH) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).
Baker Biotech Capital (GP), LLC in NEUROGEN CORP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Biotech Capital (GP), LLC: Director
Holdings: 3,500,059 shares
Latest Transaction: Nov 13 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Baker Biotech Capital (GP), LLC in NEUROGEN CORP
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, ALTH, IBPI, AUXL, BCRX, GHDX, IDRA, INCY, NRGN, PCYC, SGEN, VPHM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 13 2008 | NRGN | NEUROGEN CORP | Baker Biotech Capital (GP), LL ... | Director | Option Exercise | C | 0.00 | 50,175 | 0 | 0 | |
| Nov 13 2008 | NRGN | NEUROGEN CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | C | 0.00 | 1,304,550 | 0 | 3,500,059 | 2.2 M to 3.5 M (+59.42 %) |
| Apr 15 2008 | NRGN | NEUROGEN CORP | Baker Biotech Capital (GP), LL ... | Director | Option Exercise | P | 2.30 | 50,175 | 115,403 | 50,175 | |
| Apr 15 2008 | NRGN | NEUROGEN CORP | Baker Biotech Capital (GP), LL ... | Director | Option Exercise | P | 0.00 | 50,175 | 0 | 50,175 |
Page: 1